Literature DB >> 18706894

Unaltered SNARE complex formation in an in vivo model of prion disease.

Ayodeji A Asuni1, Colm Cunningham, Piranavhan Vigneswaran, V Hugh Perry, Vincent O'Connor.   

Abstract

The ME7 model of prion disease is a chronic slowly evolving model of neurodegeneration in which cell death is preceded by synaptic dysfunction. Previous studies in cell culture show that accumulation of misfolded prion inhibits the formation of the SNARE complexes involving synaptobrevin, syntaxin and SNAP-25 that play an essential role in neurotransmitter release. Such observations suggest that similar phenomenon may contribute to synaptic dysfunction observed in vivo. We have thus used detergent extraction of hippocampal tissue to investigate the status of SNARE complexes in the ME7 model. In the presence of increasing PrP(Sc) deposition we failed to see a change in the amount of SNARE complexes directly extracted into SDS and resolved by SDS-PAGE. Conversely pre-extraction in Triton X-100, a treatment that promotes SNARE complexes ex vivo, demonstrated a modest reduction in hippocampal SNARE complexes when homogenates were made from tissue at late stage disease. This suggests that accumulated PrP(Sc), or perhaps fibrillar complexes formed of prion only inhibit SNARE complexes that are formed ex vivo following biochemical extraction. Thus the accumulation of PrP(Sc) although deleterious to synaptic function in vivo, does not exert its synaptic effects by disrupting the formation of SNARE complexes that are core to transmitter release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706894     DOI: 10.1016/j.brainres.2008.07.083

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity.

Authors:  Franc Llorens; José Antonio Del Río
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

2.  Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease.

Authors:  Zuzana Sisková; Don Joseph Mahad; Carianne Pudney; Graham Campbell; Mark Cadogan; Ayodeji Asuni; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

3.  Silencing synapses: a route to understanding synapse degeneration in chronic neurodegenerative disease.

Authors:  Matteo Caleo; Laura Restani; V Hugh Perry
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

4.  Accumulation of α-synuclein triggered by presynaptic dysfunction.

Authors:  Yasuto Nakata; Toru Yasuda; Masahiro Fukaya; Saori Yamamori; Makoto Itakura; Tomoko Nihira; Hideki Hayakawa; Aya Kawanami; Masakazu Kataoka; Makiko Nagai; Hiroyuki Sakagami; Masami Takahashi; Yoshikuni Mizuno; Hideki Mochizuki
Journal:  J Neurosci       Date:  2012-11-28       Impact factor: 6.167

5.  Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration.

Authors:  Ayodeji A Asuni; Bryony Gray; Joanne Bailey; Paul Skipp; V Hugh Perry; Vincent O'Connor
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

6.  Differential gene expression in chronic wasting disease-positive white-tailed deer (Odocoileus virginianus).

Authors:  Emma K Trone-Launer; Jun Wang; Guoqing Lu; Nohra E Mateus-Pinilla; Paige R Zick; James T Lamer; Paul A Shelton; Christopher N Jacques
Journal:  Ecol Evol       Date:  2019-10-30       Impact factor: 2.912

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.